ロード中...
Efficacy of mirabegron for overactive bladder with human T cell lymphotropic virus‐1 associated myelopathy
OBJECTIVE: Mirabegron is widely considered as an effective and safe drug for patients with overactive bladder (OAB). However, there is no evidence regarding the efficacy of mirabegron in human T cell lymphotropic virus‐1 (HTLV‐1)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients...
保存先:
| 出版年: | Low Urin Tract Symptoms |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Publishing Asia Pty Ltd
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7379193/ https://ncbi.nlm.nih.gov/pubmed/29473309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/luts.12218 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|